Kisho is an information platform, not a medical provider. Nothing on this site constitutes medical advice, diagnosis, or treatment recommendations. All content is aggregated from publicly available sources (including ClinicalTrials.gov, PubMed, FDA.gov, and Orphanet) and is provided for informational purposes only. Clinical trial eligibility, treatment decisions, and any health-related actions should always be discussed with a qualified healthcare professional. Kisho does not endorse any specific therapy, organization, or clinical trial. Terms of use · Privacy policy
Biomarker and diagnostic research for autoimmune enteropathy type 3 has been reported in the published literature.
No clinical trials have been registered for autoimmune enteropathy type 3.
5 publications have been identified in PubMed for autoimmune enteropathy type 3. Research spans Review / Meta-Analysis (60%), Diagnostic / Biomarker (20%), and Epidemiology / Natural History (20%).
Butler K (2026). [PMID: 41782401](https://pubmed.ncbi.nlm.nih.gov/41782401/). *Curr Opin Gastroenterol*. [Review / Meta-Analysis]
Liu Y (2025). [PMID: 40316945](https://pubmed.ncbi.nlm.nih.gov/40316945/). *BMC Pediatr*. [Review / Meta-Analysis]
Xue S (2025). [PMID: 40698092](https://pubmed.ncbi.nlm.nih.gov/40698092/). *Front Immunol*. [Epidemiology / Natural History]
Iyengar VV (2025). [PMID: 41142805](https://pubmed.ncbi.nlm.nih.gov/41142805/). *Front Immunol*. [Review / Meta-Analysis]
Niehues T (2024). [PMID: 39381601](https://pubmed.ncbi.nlm.nih.gov/39381601/). *Allergol Select*. [Diagnostic / Biomarker]
Data assembled from 3 of 12 sources · Last updated Sep 20, 2026, 12:11 PM UTC
European rare disease database